| Current Price | $4.53 | Mkt Cap | $199.7M |
|---|---|---|---|
| Open | $4.51 | P/E Ratio | 0.00 |
| Prev. Close | $4.53 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $4.42 - $4.61 | Volume | 318,043 |
| 52-Wk Range | $3.53 - $10.02 | Avg. Daily Vol. | 346,500 |
| Current Price | $4.53 | Mkt Cap | $199.7M |
|---|---|---|---|
| Open | $4.51 | P/E Ratio | 0.00 |
| Prev. Close | $4.53 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $4.42 - $4.61 | Volume | 318,043 |
| 52-Wk Range | $3.53 - $10.02 | Avg. Daily Vol. | 346,500 |
The best Bull and Bear pitches based on recency and number of recommendations.
I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock… More
Read the most recent pitches from players about EIGR.
Recs
oscillation
(71.16)
Submitted: 5/28/2015 9:24:56 AM :
Start Price:
$32.40
NASDAQ:EIGR Score:
-177.12
nev
Recs
treasureoaks
(< 20)
Submitted: 4/22/2015 3:54:19 PM :
Start Price:
$203.85
NASDAQ:EIGR Score:
-190.47
Oversold.
Recs
Jimbyrnes1969
(< 20)
Submitted: 4/9/2015 1:25:22 PM :
Start Price:
$252.36
NASDAQ:EIGR Score:
-193.09
I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock 300% in the short term but the real value will be when the therapy hits the market.
Find the members with the highest scoring picks in EIGR.
GreenAB (29.28) Score: +192.20
The Score Leader is the player with the highest score across all their picks in EIGR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| GreenAB | 29.28 | 3/20/2015 |
|
NS | $405.00 | -98.88% | +93.32% | +192.20 | 0 Comment | |
| IdahoInvestor | 27.65 | 8/17/2015 |
|
5Y | $15.75 | -71.11% | +94.48% | +165.59 | 0 Comment | |
|
OneBee | < 20 | 5/4/2021 |
|
3M | $8.67 | -47.52% | -2.46% | -45.06 | 0 Comment |
| foggs1 | 68.98 | 3/17/2021 |
|
5Y | $10.12 | -55.04% | +2.88% | -57.92 | 0 Comment | |
| sikiliza | < 20 | 3/13/2020 |
|
5Y | $5.71 | -20.32% | +54.21% | -74.52 | 0 Comment | |
| odocoileus | 56.93 | 9/10/2020 |
|
5Y | $10.48 | -56.58% | +21.18% | -77.77 | 0 Comment | |
| drugtrader | 64.72 | 7/8/2020 |
|
5Y | $9.43 | -51.75% | +29.74% | -81.49 | 0 Comment | |
| BigDreamer | 53.16 | 1/29/2018 |
|
3Y | $8.95 | -49.16% | +41.95% | -91.12 | 0 Comment | |
| skyrocket29 | 67.23 | 1/16/2018 |
|
3M | $9.10 | -50.00% | +45.09% | -95.09 | 0 Comment | |
| naughtyguy | 71.37 | 8/21/2019 |
|
5Y | $10.56 | -56.93% | +38.93% | -95.86 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
